CRA was retained in an international arbitration between two Japanese affiliates of multinational pharmaceutical companies. The dispute concerned Respondent’s performance under a co-promotion agreement. CRA’s team of life sciences consultants assessed indicators of commercially reasonable efforts using various industry data sources. The CRA team also quantified Claimant’s loss resulting from the alleged inadequate performance under the agreement, and responded to Respondent’s expert regarding damages alleged by Respondent.
CRA consultants recognized in Lexology Index: Arbitration Expert Witnesses Report
We congratulate Tiago Duarte-Silva, who has been recognized as a Thought Leader, and Greg Bell, who has been recognized as Highly Recommended. This...